Clinical Trials Directory

Trials / Conditions / Spontaneous Bacterial Peritonitis

Spontaneous Bacterial Peritonitis

41 registered clinical trials studyying Spontaneous Bacterial Peritonitis7 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingPredicting and Monitoring Spontaneous Bacterial Peritonitis in Cirrhotic Patients Using the Mansoura Scoring S
NCT07024355
Assiut University
Not Yet RecruitingPrediction of SBP in Cirrhotic Patients by Platlet Count, Na and AlBl Index.
NCT07116369
Sohag University
Not Yet RecruitingFrequency and Predictors of Recurrent SBP in Cirrhotic Patients in Al Rajhi University Hospital
NCT06778616
Assiut University
Not Yet RecruitingEarly Ascitis Parencentesis in SBP
NCT06679842
Centre Hospitalier Universitaire de BesanconN/A
UnknownEfficacy of Rifaximin vs Norfloxacin for Secondary Prophylaxis of SBP (NORRIF Trial)
NCT06199843
Institute of Liver and Biliary Sciences, IndiaN/A
RecruitingEfficacy of Conventional Dose Protocol vs Low Dose Protocol Albumin Use in Patients With Cirrhosis and High Ri
NCT06026267
Institute of Liver and Biliary Sciences, IndiaN/A
CompletedRifaximin as a Prophylaxis of Spontaneous Bacterial Peritonitis in Comparison With Ciprofloxacin
NCT06234046
Ain Shams UniversityPhase 3
UnknownLaboratory Diagnosis of Spontaneous Bacterial Peritonitis
NCT05696054
Sohag University
UnknownMeropenem vs Cefotaxime as Empirical Treatment of SBP
NCT05427747
Assiut UniversityPhase 4
UnknownAscitic Fluid Calprotectin as an Accurate Diagnostic Marker for Spontaneous Bacterial Peritonitis
NCT05422118
Sohag UniversityN/A
CompletedSerum Copeptin in Cirrhotic Patients With Spontaneous Bacterial Peritonitis
NCT05401721
Sohag University
CompletedComparative Study of Secondary Prophylaxis for SBP
NCT06827756
Tanta UniversityPhase 4
UnknownNitazoxanide in Prevention of Secondary Spontaneous Peritonitis
NCT04746937
Tanta UniversityPhase 3
CompletedMPV and NLR as Predictors of SBP Diagnosis
NCT04775420
Sohag University
CompletedLow Dose Albumin Versus Standard Dose Albumin in High Risk Spontaneous Bacterial Peritonitis.
NCT04273373
Institute of Liver and Biliary Sciences, IndiaN/A
UnknownA Randomized Controlled Trial Comparing Imipenem and Tigecycline Versus Imipenem and Tigecycline With GM-CSF f
NCT04208763
Institute of Liver and Biliary Sciences, IndiaN/A
UnknownRifaximin Versus Norfloxacin in Spontaneous Bacterial Peritonitis
NCT04159870
Ospedali Riuniti di FoggiaPhase 3
CompletedDoxycycline for the Prevention of Spontaneous Bacterial Peritonitis
NCT04153604
Methodist Health System
UnknownPrimary Antibiotic Prophylaxis Using Co-trimoxazole to Prevent Spontaneous Bacterial Peritonitis in Cirrhosis
NCT04395365
University College, LondonPhase 3
CompletedAsymptomatic Spontaneous Bacterial Peritonitis in Patients With Decompensated Liver Cirrhosis
NCT03163745
Assiut University
RecruitingOral Gemifloxacin Versus Intravenous Cefotaxime in Treatment of Spontaneous Bacterial Peritonitis
NCT04168099
Tanta UniversityPhase 3
RecruitingNorfloxacin With Itopride Versus Norfloxacin in Secondary Prophylaxis of Spontaneous Bacterial Peritonitis
NCT04161768
Tanta UniversityPhase 3
CompletedComparison of the Efficacy of Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) and Norfloxacin in Sec
NCT03702426
Institute of Liver and Biliary Sciences, IndiaN/A
UnknownA Study on Diagnosis and Treatment of End Stage Liver Disease Complicated With Infection (SESLDIP Study)
NCT03362632
Tongji Hospital
WithdrawnStudy of the Effect of Adjunctive Vivomixx® in Patients With Cirrhosis and Spontaneous Bacterial Peritonitis (
NCT02552862
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauPhase 3
UnknownEvaluation of Serum Amyloid A in Early Diagnosis of Spontaneous Bacterial Peritonitis
NCT02759497
Tanta University
CompletedEvaluation of Serum-Derived Bovine Immunoglobulin Protein Isolate in Subjects With Decompensated Cirrhosis Wit
NCT02608658
St. Louis UniversityN/A
CompletedTo Compare the Efficacy of Carbepenem Versus Carbepenem Plus GM-CSF in Difficult To Treat Spontaneous Bacteria
NCT02468089
Institute of Liver and Biliary Sciences, IndiaN/A
CompletedCefotaxime Resistance in Treatment of Spontaneous Bacterial Peritonitis
NCT02388035
Dr Ahmed Ali ElbazN/A
UnknownComparative Study of Rifaximin Versus Norfloxacin in the Secondary Prophylaxis of Spontaneous Bacterial Perito
NCT02120196
Sherief Abd-ElsalamPhase 3
WithdrawnRifaximin for the Secondary Prevention of Spontaneous Bacterial Peritonitis Recurrence in Cirrhotic Patients
NCT02011841
Seoul National University HospitalPhase 3
CompletedImipenem Versus Cefepime in Spontaneous Bacterial Peritonitis and to Evaluate the Risk Factors for Treatment F
NCT01852630
Institute of Liver and Biliary Sciences, IndiaN/A
UnknownDiagnosis of Spontaneous Bacterial Peritonitis
NCT01598870
Azienda Ospedaliera di Lecco
CompletedDiagnostic of Spontaneous Bacterial Peritonitis
NCT01193426
Centre Hospitalier Universitaire de Nice
TerminatedA Comparison of Two Albumin Administration Schedules for Spontaneous Bacterial Peritonitis
NCT02528097
NYU Langone HealthN/A
CompletedStudy on B-blockers to Prevent Decompensation of Cirrhosis With HTPortal
NCT01059396
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauPhase 4
UnknownRole of Probiotics in the Prevention of Spontaneous Bacterial Peritonitis in Cirrhotic Patients: A Randomized
NCT00678613
All India Institute of Medical SciencesPhase 2 / Phase 3
TerminatedClinical, Inflammatory, and Economic Impact of Dextran 70 in Treating Spontaneous Bacterial Peritonitis
NCT00570960
University of VirginiaPhase 4
UnknownRandomized Comparison of Two Albumin Administration Schedules for Spontaneous Bacterial Peritonitis (SBP)
NCT00761098
Weill Medical College of Cornell UniversityPhase 4
CompletedNorfloxacin In The Primary Prophylaxis Of Spontaneous Bacterial Peritonitis
NCT00359853
Hospital Clinic of BarcelonaPhase 4
CompletedSpontaneous Bacterial Peritonitis: Incidence, Risk Factors and Outcome
NCT00490217
Tampere University